McNaught K S, Thull U, Carrupt P A, Altomare C, Cellamare S, Carotti A, Testa B, Jenner P, Marsden C D
Neurodegenerative Diseases Research Centre, King's College, London, U.K.
Biochem Pharmacol. 1996 Jun 14;51(11):1503-11. doi: 10.1016/0006-2952(96)00091-3.
Isoquinoline derivatives exert 1-methyl-4-phenylpyridinium (MPP+)-like activity as inhibitors of complex I and alpha-ketoglutarate dehydrogenase activity in rat brain mitochondrial fragments. We now examine the ability of 19 isoquinoline derivatives and MPP+ to accumulate and inhibit respiration in intact rat liver mitochondria, assessed using polarographic techniques. None of the compounds examined inhibited respiration supported by either succinate + rotenone or tetramethylparaphenylenediamine (TMPD) + ascorbate. However, with glutamate + malate as substrates, 15 isoquinoline derivatives and MPP+ inhibited state 3 and, to a lesser extent, state 4 respiration in a time-dependent manner. None of the isoquinoline derivatives were more potent than MPP+. 6,7-Dimethoxy-1-styryl-3,4-dihydroisoquinoline uncoupled mitochondrial respiration. Qualitative structure-activity relationship studies revealed that isoquinolinium cations were more active than isoquinolines in inhibiting mitochondrial respiration; these, in turn, were more active than dihydroisoquinolines and 1,2,3,4-tetrahydroisoquinolines. Three-dimensional quantitative structure-activity relationship studies using Comparative Molecular Field Analysis showed that the inhibitory potency of isoquinoline derivatives was determined by steric, rather than electrostatic, properties of the compounds. A hypothetical binding site was identified that may be related to a rate-limiting transport process, rather than to enzyme inhibition. In conclusion, isoquinoline derivatives are less potent in inhibiting respiration in intact mitochondria than impairing complex I activity in mitochondrial fragments. This suggests that isoquinoline derivatives are not accumulated by mitochondria as avidly as MPP+. The activity of charged and neutral isoquinoline derivatives implicates both active and passive processes by which these compounds enter mitochondria, although the quaternary nitrogen moiety of the isoquinolinium cations favours mitochondrial accumulation and inhibition of respiration. These findings suggest that isoquinoline derivatives may exert mitochondrial toxicity in vivo similar to that of MPTP/MPP+.
异喹啉衍生物作为大鼠脑线粒体片段中复合体I和α-酮戊二酸脱氢酶活性的抑制剂,具有类似1-甲基-4-苯基吡啶鎓(MPP+)的活性。我们现在使用极谱技术,研究19种异喹啉衍生物和MPP+在完整大鼠肝线粒体中积累和抑制呼吸的能力。所检测的化合物均未抑制由琥珀酸+鱼藤酮或四甲基对苯二胺(TMPD)+抗坏血酸支持的呼吸。然而,以谷氨酸+苹果酸为底物时,15种异喹啉衍生物和MPP+以时间依赖性方式抑制状态3呼吸,并在较小程度上抑制状态4呼吸。没有一种异喹啉衍生物比MPP+更有效。6,7-二甲氧基-1-苯乙烯基-3,4-二氢异喹啉使线粒体呼吸解偶联。定性构效关系研究表明,异喹啉鎓阳离子在抑制线粒体呼吸方面比异喹啉更具活性;反过来,异喹啉又比二氢异喹啉和1,2,3,4-四氢异喹啉更具活性。使用比较分子场分析的三维定量构效关系研究表明,异喹啉衍生物的抑制效力取决于化合物的空间性质,而非静电性质。确定了一个假设的结合位点,该位点可能与限速转运过程有关,而非与酶抑制有关。总之,异喹啉衍生物在抑制完整线粒体呼吸方面的效力低于损害线粒体片段中复合体I的活性。这表明异喹啉衍生物不像MPP+那样容易被线粒体积累。带电荷和中性异喹啉衍生物的活性暗示了这些化合物进入线粒体的主动和被动过程,尽管异喹啉鎓阳离子的季铵氮部分有利于线粒体积累和呼吸抑制。这些发现表明,异喹啉衍生物在体内可能产生与MPTP/MPP+类似的线粒体毒性。